Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FL1KJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,137
Award facts
- Contract value 100% obligated
- $13,137.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on February 4, 2026, by the Defense Logistics Agency (DLA) to AmerSourceBergen Drug Corp, involves the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used for chronic obstructive pulmonary disease management. The contract, valued at $13,137.11 with a firm fixed-price structure, is a non-set-aside award and represents a child delivery order under AmerSourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The place of performance is AmerSourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026.
AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs for military and veteran healthcare systems. The company's DLA IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of diverse pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order demonstrates AmerSourceBergen's ongoing role in fulfilling federal medical supply requirements through open competition, consistent with the company's extensive portfolio of competitively awarded contracts across various medication categories and therapeutic areas supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FL1KJ?
SPE2DR26FL1KJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FL1KJ worth?
The government has obligated $13,137 on SPE2DR26FL1KJ.
Is contract SPE2DR26FL1KJ an order under another contract?
Yes. SPE2DR26FL1KJ is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL1KJ competed?
The extent of competition for SPE2DR26FL1KJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award